The Petri Dish: Embattled Sesen Bio shuts down via merger

Khosla Ventures is throwing its weight behind a new CRISPR/Cas13 startup, and Sesen Bio, formerly Eleven Biotherapeutics, is finally shutting down after 14 years.

ProKidney gets Forsyth County’s OK for incentives to expand HQ in Winston-Salem

De Soto plans ahead for 3,000-acre solar farm near Panasonic construction

Maumee Bay Brewing’s Shawnee Station Taproom expects early 2024 opening

Executive Insights: Jeff Ellison of ConfirmaMD (video)

Axuall hires Mike Bechtel to lead commercial development

Bayer picks former Genentech CEO to replace embattled boss

St. Pete developer ‘bullish’ on luxury spec homes

Austin may allow tiny homes with wheels, RVs as permanent residences

The Petri Dish: Embattled Sesen Bio shuts down via merger

Previous Limit lab construction in the world's biotech capital? A Cambridge proposal could do just that.

Next Angier accelerates growth with more new homes approved

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Lennar caters to ‘unserved’ homebuyer market in Northwest Jacksonville

Chef Kelly makes bittersweet decision to put Caenen Castle on the market

The Bluffs at Castle Rock apartments sell for $50M

Why KeyBank decided to sell its insurance business

PNC to ‘experiment in retail’ with national expansion

South Florida Homeowners Association Management Companies

MENU

FirstStar Group

More Stories

Maryland loses 4,300 jobs in April, unemployment holds steady

Previous Limit lab construction in the world's biotech capital? A Cambridge proposal could do just that.

Next Angier accelerates growth with more new homes approved

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories